Novo Nordisk
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novo Nordisk and other ETFs, options, and stocks.About NVO
Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments.
NVO Key Statistics
Stock Snapshot
Novo Nordisk(NVO) stock is priced at $48.23, giving the company a market capitalization of 215.51B. It carries a P/E multiple of 13.99 and pays a dividend yield of 2.6%.
As of 2025-12-20, Novo Nordisk(NVO) stock has fluctuated between $46.98 and $48.80. The current price stands at $48.23, placing the stock +2.7% above today's low and -1.2% off the high.
Novo Nordisk(NVO) shares are trading with a volume of 10.93M, against a daily average of 12.52M.
In the last year, Novo Nordisk(NVO) shares hit a 52-week high of $93.80 and a 52-week low of $43.08.
In the last year, Novo Nordisk(NVO) shares hit a 52-week high of $93.80 and a 52-week low of $43.08.
NVO News
Below is Validea's guru fundamental report for NOVO NORDISK A/S (ADR) (NVO). Of the 22 guru strategies we follow, NVO rates highest using our Patient Investor m...
Mixed options sentiment in Novo Nordisk (NVO), with shares up 60c, or 1.27%, near $48.22. Options volume relatively light with 20k contracts traded and calls le...
Things weren’t looking good for Vestas Wind Systems A/S in January, with the return of Donald Trump and his anti-renewables policies after an already difficult...
Analyst ratings
55%
of 33 ratingsMore NVO News
Key Points Novo Nordisk cut its guidance and changed its CEO this past year. Amid the troubling developments, the stock has nose-dived more than 40%. It trad...
Novo Nordisk A/S (NYSE:NVO) on Thursday submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for once-weekly CagriSema. The ap...
A photo illustration shows Novo Nordisk’s injectable weight-loss medication Wegovy. The company and Eli Lilly are both developing a new generation of obesity dr...
These struggling healthcare stocks haven't said their last words. Novo Nordisk (NVO +0.52%) and Intuitive Surgical (ISRG +0.99%) are both healthcare leaders, b...
The Eli Lilly & Co. logo at the company's Digital Health Innovation Hub facility in Singapore, on Thursday, Nov. 14, 2024. Eli Lilly on Thursday said its close...
Claim 50% Off TipRanks Premium and Invest with Confidence Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper...
Novo Nordisk (NVO) announced an update on their ongoing clinical study. Claim 50% Off TipRanks Premium and Invest with Confidence Unlock hedge-fund level data...